MICHAELBIGBYMDOLIVIERCHOSIDOWMD, PhDROBERT P.DELLAVALLEMD, PhD, MSPHDAIHUNGDOMDURBÀGONZÁLEZMD, PhDCATALIN M.POPESCUMD, PhDHYWELWILLIAMSMSc, PhD, FRCP
Ann Intern Med. 2009;150(3):194-198
Ann Intern Med. 2009;150(3):188-193
Question: Can screening with whole-body skin examination decrease the rate of death from melanoma?
Background: Skin cancer is the most commonly diagnosed cancer in the United States. Most skin cancers are nonmelanoma cancers, either of the basal cell or squamous cell type. The incidence of melanoma and nonmelanoma skin cancer has been increasing for the past 3 decades.
Bigby M. Why the Evidence for Skin Cancer Screening Is InsufficientLessons From Prostate Cancer Screening. Arch Dermatol. 2010;146(3):322–324. doi:10.1001/archdermatol.2010.18
* * SCHEDULED MAINTENANCE * *
The JAMA Network Sites will be conducting routine maintenance from 10/20/2017 through 10/21/2017. During this window access to content and authentication may be intermittently available. The JAMA Store will be completely unavailable during the maintenance window.